OMO Consultants

OMO Consultants is a private, London-based consultancy serving the digital health, biopharma, and medical device sectors since 2015. The company operates on a services business model, generating revenue by providing expert guidance on quality systems, regulatory affairs, clinical trial processes, and GxP compliance. It positions itself as a strategic partner to its clients, aiming to reduce time-to-market and enhance patient safety through professional excellence and a strong quality focus. The firm is likely in a revenue-generating stage, with its growth tied to the expanding regulatory demands of the life sciences industry.

Accumulated regulatory, quality, and compliance expertise across biopharma and medical device lifecycles; methodology for quality system design, audit support, and inspection readiness; provision of Qualified Person (QP) and Responsible Person (RP) services.

OMO competes in a fragmented market with large global players (e.g., IQVIA, Parexel, PwC) offering broad consulting and many small, specialized consultancies. Differentiation is achieved through niche expertise (e.g., QP services), a partnership approach, and deep, hands-on regulatory and quality operational experience. The lack of a proprietary technology platform means competition is based purely on knowledge, reputation, and client relationships.